This website uses cookies
Read our Privacy policy and Terms of use for more information.
Find the content you are looking for on Diabetech by searching the desired device, company, or topic.
Sep 14, 2026
•
1 min read
Mint launches fully in Q1 2027, and its new 3D Intelligence algorithm gives clinicians three dosing options to better fit each patient's needs.
The Eversense 365 implantable continuous glucose monitor will expand support to a second insulin pump before the end of the year.
Sep 11, 2026
MiniMed’s first tubeless insulin pump could arrive summer 2027 with unique features setting it apart from the other patch pumps on the market.
Eledon's CEO joined the podcast to break down the company’s promising trial results, the history of tegoprubart, and how he plans to make transplants more accessible.
Sep 4, 2026
We take a look at Europe’s insulin pump landscape, how access varies by country, and the trends shaping the future of AID systems.
When Levemir was discontinued in the U.S., Allison Smart began a national advocacy effort to bring it back—and to preserve treatment choice for people with diabetes.